Loading...
Beyond Air, Inc.
XAIR•NASDAQ
Healthcare
Medical - Devices
$3.20
$-0.12(-3.61%)
Beyond Air, Inc. (XAIR) Financial Performance & Income Statement Overview
Review Beyond Air, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
-22.33%
↓ 22.33%
Net Income Growth
-7.93%
↓ 7.93%
Operating Cash Flow Growth
-69.69%
↓ 69.69%
Operating Margin
-1202.13%
↓ 1202.13%
Gross Margin
-44.91%
↓ 44.91%
Net Profit Margin
-1258.43%
↓ 1258.43%
ROE
-247.08%
↓ 247.08%
ROIC
-177.72%
↓ 177.72%
Beyond Air, Inc. (XAIR) Income Statement & Financial Overview
Review Beyond Air, Inc.'s (XAIR) income statement with detailed quarterly and annual figures.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $1.07M | $798000.00 | $683000.00 | $470000.00 |
| Cost of Revenue | $1.29M | $1.88M | $1.02M | $983000.00 |
| Gross Profit | -$215000.00 | -$1.08M | -$333000.00 | -$513000.00 |
| Gross Profit Ratio | -$0.20 | -$1.36 | -$0.49 | -$1.09 |
| R&D Expenses | $3.005M | $4.58M | $6.009M | $5.70M |
| SG&A Expenses | $7.73M | $7.16M | $7.24M | $6.42M |
| Operating Expenses | $10.74M | $11.75M | $13.25M | $12.12M |
| Total Costs & Expenses | $12.02M | $13.63M | $14.26M | $13.10M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $549000.00 | $927000.00 | $964000.00 | $921000.00 |
| Depreciation & Amortization | $856000.00 | $946000.00 | $830000.00 | $737000.00 |
| EBITDA | -$11.93M | -$12.16M | -$11.26M | -$12.90M |
| EBITDA Ratio | -$11.13 | -$15.23 | -$16.49 | -$27.44 |
| Operating Income | -$10.95M | -$12.83M | -$13.58M | -$12.63M |
| Operating Income Ratio | -$10.22 | -$16.08 | -$19.88 | -$26.88 |
| Other Income/Expenses (Net) | -$2.38M | -$1.20M | $525000.00 | -$1.92M |
| Income Before Tax | -$13.33M | -$14.03M | -$13.05M | -$14.56M |
| Income Before Tax Ratio | -$12.44 | -$17.58 | -$19.11 | -$30.97 |
| Income Tax Expense | $0.00 | -$671000.00 | $0.00 | -$849000.00 |
| Net Income | -$13.03M | -$13.36M | -$12.20M | -$13.71M |
| Net Income Ratio | -$12.16 | -$16.74 | -$17.86 | -$29.16 |
| EPS | -$0.15 | -$0.14 | -$0.14 | -$0.18 |
| Diluted EPS | -$0.15 | -$0.14 | -$0.14 | -$0.18 |
| Weighted Avg Shares Outstanding | $88.07M | $94.24M | $91.80M | $76.75M |
| Weighted Avg Shares Outstanding (Diluted) | $88.07M | $94.24M | $91.80M | $76.75M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan